(Q31118982)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27481022%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Exploiting Pharmacological Similarity to Identify Safety Concerns - Listen to What the Data Tells You (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27481022%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27481022%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Scott Boyer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27481022%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

14 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27481022%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

published in

Molecular Informatics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27481022%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27481022%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27481022%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

37-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27481022%20AND%20SRC:MED&resulttype=core&format=json

Can the pharmaceutical industry reduce attrition rates?

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Trial watch: Phase II failures: 2008-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Computational toxicology in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Computational methods for early predictive safety assessment from biological and chemical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

A framework to assess the translation of safety pharmacology data to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Concordance of the toxicity of pharmaceuticals in humans and in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Development, interpretation and temporal evaluation of a global QSAR of hERG electrophysiology screening data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Interpretation of nonlinear QSAR models applied to Ames mutagenicity data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Use of QSARs in international decision-making frameworks to predict ecologic effects and environmental fate of chemical substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Comparison of molecular fingerprint methods on the basis of biological profile data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

A ligand-based approach to mining the chemogenomic space of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Chemogenomic data analysis: prediction of small-molecule targets and the advent of biological fingerprint

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Drug target identification using side-effect similarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Chemical and biological profiling of an annotated compound library directed to the nuclear receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Global mapping of pharmacological space

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Biological spectra analysis: Linking biological activity profiles to molecular structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Biospectra analysis: model proteome characterizations for linking molecular structure and biological response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Analysis of drug-induced effect patterns to link structure and side effects of medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Predicting ligand binding to proteins by affinity fingerprinting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Anticipating drug side effects by comparative pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

In Silico Receptorome Screening of Antipsychotic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Ligand-based approach to in silico pharmacology: nuclear receptor profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Mapping adverse drug reactions in chemical space.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Predicting new molecular targets for known drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Relating protein pharmacology by ligand chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Drug effect prediction by polypharmacology-based interaction profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Associating Drugs, Targets and Clinical Outcomes into an Integrated Network Affords a New Platform for Computer-Aided Drug Repurposing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Do structurally similar molecules have similar biological activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Cheminformatic tools for medicinal chemists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Peptide quantitative structure-activity relationships, a multivariate approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Comparing Measures of Promiscuity and Exploring Their Relationship to Toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Can we discover pharmacological promiscuity early in the drug discovery process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Integration of biological networks and gene expression data using Cytoscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Network pharmacology: the next paradigm in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

The chemical basis of pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Ontologies and semantic data integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201200088

Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity

21 January 2018

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201200088

Large-scale prediction and testing of drug activity on side-effect targets

8 April 2023

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201200088

The use of computer models in pharmaceutical safety evaluation.

8 April 2023

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201200088

In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry survey

8 April 2023

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201200088

8 April 2023

Identifiers

DOI

10.1002/MINF.201200088

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27481022%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference